Table 3 The pooled mean and mean difference of clinical data in spondyloarthritis patients with and without uveitis of the included studies.
From: The effect of uveitis and undiagnosed spondyloarthritis: a systematic review and meta-analysis
Subgroup | Uveitis (+) | Uveitis (–) | Mean difference | 95% CI | p value (I2) | ||
|---|---|---|---|---|---|---|---|
Pooled mean | 95% CI | Pooled mean | 95% CI | ||||
Delay diagnosis (y) | 6.08 | 4.77 to 7.38 | 5.41 | 3.94 to 6.89 | 1.04 | 0.28 to 1.80 | 0.008 (83%) |
ASDAS | 2.47 | 2.31 to 2.64 | 2.32 | 2.15 to 2.50 | 0.18 | 0.11 to 0.25 | < 0.001 (0%) |
BASDAI | 4.87 | 4.41 to 5.32 | 4.53 | 4.11 to 4.96 | 0.11 | − 0.06 to 0.28 | 0.21 (76%) |
BASFI | 3.89 | 3.53 to 4.25 | 3.97 | 3.65 to 4.28 | − 0.12 | − 0.46 to 0.21 | 0.47 (92%) |
CRP (mg/L) | 15.78 | 8.38 to 23.18 | 14.53 | 8.69 to 20.38 | 1.48 | − 0.17 to 3.14 | 0.08 (64%) |
ESR (mm/h) | 28.19 | 7.64 to 48.75 | 28.16 | 17.91 to 38.42 | − 0.80 | − 4.62 to 3.03 | 0.68 (90%) |
ASDAS-CRP | 2.42 | 2.26 to 2.59 | 2.31 | 2.11 to 2.51 | 0.17 | 0.10 to 0.24 | < 0.001 (0%) |
ASDAS-ESR | 2.76 | 2.47 to 3.05 | 2.37 | 2.26 to 2.48 | 0.03 | − 0.65 to 0.72 | 0.92 (94%) |
Subgroup | BASDAI | BASFI | Study number | ||||
|---|---|---|---|---|---|---|---|
Pooled mean | 95% CI | Pooled mean | 95% CI | ||||
≤ 2 years | 4.46 | 4.32 to 4.61 | 2.92 | 2.48 to 3.37 | 1 (6) | ||
> 2 years, ≤ 5 years | 5.60 | 5.47 to 5.73 | 3.98 | 3.67 to 4.28 | 2 (22, 23) | ||
> 5 years, ≤ 10 years | 4.40 | 4.32 to 4.49 | 4.06 | 3.91 to 4.20 | 3 (15, 17, 19) | ||
> 10 years | 3.74 | 2.63 to 4.85 | 4.17 | 2.93 to 5.41 | 1 (18) | ||
